The present invention discloses pyrrolotriazinone derivatives for use as inhibitors of stearoyl-CoA desaturase having the structure of Formula I:
The compounds are useful in treating and/or preventing various human diseases, mediated by stearoyl-CoA desaturase (SCD) enzymes, especially diseases related to abnormal lipid levels, cardiovascular disease, diabetes, obesity, metabolic syndrome and the like.
本发明揭示了用于作为
硬脂酰辅酶A去饱和酶
抑制剂的
吡咯并
三氮烯衍
生物,其具有式I的结构:这些化合物可用于治疗和/或预防由
硬脂酰辅酶A去饱和酶(SCD)酶介导的各种人类疾病,特别是与异常脂质
水平、心血管疾病、糖尿病、肥胖症、代谢综合征等相关的疾病。